Patent details

EP3953357 Title: PYRROLOTRIAZINE DERIVATIVES FOR TREATING KIT- AND PDGFRA-MEDIATED DISEASES

Basic Information

Publication number:
EP3953357
PCT Application Number:
US2020027177
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP207210832
PCT Publication Number:
WO2020210293
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PYRROLOTRIAZINE DERIVATIVES FOR TREATING KIT- AND PDGFRA-MEDIATED DISEASES
French Title of Invention:
DÉRIVÉS DE PYRROLOTRIAZINE POUR LE TRAITEMENT DE MALADIES LIÉES AU KIT- AND PDGFRA
German Title of Invention:
PYRROLOTRIAZINEDERIVATE ZUR BEHANDLUNG VON KIT- UND PDGFRA-VERBUNDENEN KRANKHEITEN
SPC Number:

Dates

Filing date:
08/04/2020
Grant date:
17/04/2024
EP Publication Date:
16/02/2022
PCT Publication Date:
15/10/2020
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/04/2024
EP B1 Publication Date:
17/04/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
08/04/2040
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/04/2024
 
 

Name:
Blueprint Medicines Corporation
Address:
45 Sidney Street, Cambridge, MA 02139, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
17/05/2024
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
GUZI, Timothy
Address:
United States (US)

2

Name:
KIM, Joseph, L.
Address:
United States (US)

3

Name:
DINEEN, Thomas, A.
Address:
United States (US)

Priority

1

Priority Number:
201962833529 P
Priority Date:
12/04/2019
Priority Country:
United States (US)

2

Priority Number:
201962911016 P
Priority Date:
04/10/2019
Priority Country:
United States (US)

3

Priority Number:
201962930240 P
Priority Date:
04/11/2019
Priority Country:
United States (US)

Classification

IPC classification:
C07D 487/04; A61P 35/00; A61K 31/53;

Publication

European Patent Bulletin

1

Issue number:
202416
Publication date:
17/04/2024
Description:
Grant (B1)

2

Issue number:
202421
Publication date:
22/05/2024
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
30/04/2027
Annual Fee Number:
8
Annual Fee Amount:
99 Euro
Expected Payer:
Last Annual Fee Payment Date:
26/03/2026
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
82 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
17/05/2024 Power Of Attorney 1
17/05/2024 Outgoing Correspondence 1